tozorakimab

From Aaushi
(Redirected from Tozorakimab)
Jump to navigation Jump to search

Indications

More general terms

References

  1. AstraZeneca Tozorakimab met primary endpoint in both OBERON and TITANIA Phase III trials in patients with COPD. AstraZeneca. March 27, 2026 https://www.astrazeneca.com/media-centre/press-releases/2026/tozorakimab-met-primary-endpoint-in-oberon-titania-phase-iii-trials-in-patients-with-copd.html